Presence of an Artificial Intelligence–powered Predictive Biomarker Is Associated with a Poor Response to Intravesical Bacillus Calmette-Guerin but Not to Intravesical Sequential Gemcitabine/Docetaxel in Patients with High-grade Non–muscle-invasive Bladder CancerVignesh T. Packiam, Patrick J. Hensley, Derek B. Allison et al.|European Urology Oncology|2025Cited by 6
Management of Renal Cell Carcinoma With Supradiaphragmatic Inferior Vena Cava Thrombus Diagnosed During Acute COVID-19 InfectionMichael Leyderman, Vignesh T. Packiam, Ian M. McElree et al.|Cureus|2024Cited by 0
Impact of gene expression signatures of immune infiltration on response to sequential intravesical gemcitabine and docetaxel versus bacillus Calmette-Guerin in high-risk non-muscle-invasive bladder cancer.Vignesh T. Packiam, Michael A. O’Donnell, Ian M. McElree et al.|Journal of Clinical Oncology|2025Cited by 0